PAM
UTHR icon

Panagora Asset Management’s United Therapeutics UTHR Stock Holding History

Panagora Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
2,880
-32,073
-92% -$18.1M ﹤0.01% 674
2026
Q1 		$20.7M Buy
34,953
+33,869
+3,124% +$16.9M 0.08% 225
2025
Q4 		$528K Sell
1,084
-18,231
-94% -$8.49M ﹤0.01% 858
2025
Q3 		$8.1M Sell
19,315
-65,828
-77% -$22.1M 0.03% 299
2025
Q2 		$24.5M Buy
85,143
+65,828
+341% +$19.7M 0.11% 177
2025
Q1 		$5.95M Buy
19,315
+18,248
+1,710% +$6.25M 0.03% 319
2024
Q4 		$376K Sell
1,067
-3,963
-79% -$1.46M ﹤0.01% 898
2024
Q3 		$1.8M Sell
5,030
-699
-12% -$236K 0.01% 553
2024
Q2 		$1.82M Sell
5,729
-1,372
-19% -$363K 0.01% 548
2024
Q1 		$1.63M Buy
7,101
+426
+6% +$96.1K 0.01% 637
2023
Q4 		$1.47M Buy
6,675
+5,429
+436% +$1.25M 0.01% 676
2023
Q3 		$281K Sell
1,246
-5
-0.4% -$1.15K ﹤0.01% 1084
2023
Q2 		$276K Buy
1,251
+146
+13% +$32.3K ﹤0.01% 1104
2023
Q1 		$247K Hold
1,105
– – ﹤0.01% 1310
2022
Q4 		$307K Buy
1,105
+27
+3% +$6.82K ﹤0.01% 1276
2022
Q3 		$226K Sell
1,078
-24,675
-96% -$5.52M ﹤0.01% 1345
2022
Q2 		$6.07M Buy
25,753
+18,783
+269% +$3.82M 0.04% 344
2022
Q1 		$1.25M Buy
6,970
+6
+0.1% +$1.14K 0.01% 839
2021
Q4 		$1.5M Sell
6,964
-154,777
-96% -$30.4M 0.01% 751
2021
Q3 		$29.9M Sell
161,741
-3,722
-2% -$733K 0.16% 138
2021
Q2 		$29.7M Sell
165,463
-17,536
-10% -$3.34M 0.16% 149
2021
Q1 		$30.6M Sell
182,999
-19,415
-10% -$3.24M 0.17% 136
2020
Q4 		$30.7M Buy
202,414
+158,861
+365% +$20.8M 0.18% 123
2020
Q3 		$4.4M Buy
43,553
+42,263
+3,276% +$4.64M 0.03% 422
2020
Q2 		$156K Sell
1,290
-6
-0.5% -$675 ﹤0.01% 1635
2020
Q1 		$123K Buy
1,296
+9
+0.7% +$855 ﹤0.01% 1621
2019
Q4 		$113K Buy
1,287
+220
+21% +$19.4K ﹤0.01% 1770
2019
Q3 		$85K Hold
1,067
– – ﹤0.01% 1873
2019
Q2 		$83K Sell
1,067
-6,061
-85% -$567K ﹤0.01% 2002
2019
Q1 		$837K Buy
7,128
+2,543
+55% +$296K ﹤0.01% 1198
2018
Q4 		$499K Sell
4,585
-4
-0.1% -$464 ﹤0.01% 1336
2018
Q3 		$587K Buy
4,589
+8
+0.2% +$990 ﹤0.01% 1328
2018
Q2 		$518K Buy
4,581
+2,227
+95% +$245K ﹤0.01% 1374
2018
Q1 		$264K Sell
2,354
-1,711
-42% -$217K ﹤0.01% 1587
2017
Q4 		$601K Buy
4,065
+46
+1% +$5.85K ﹤0.01% 1309
2017
Q3 		$471K Buy
4,019
+2,013
+100% +$257K ﹤0.01% 1375
2017
Q2 		$260K Buy
2,006
+138
+7% +$17.2K ﹤0.01% 1550
2017
Q1 		$253K Sell
1,868
-1,190
-39% -$180K ﹤0.01% 1580
2016
Q4 		$439K Sell
3,058
-14,307
-82% -$1.83M ﹤0.01% 1486
2016
Q3 		$2.05M Sell
17,365
-1,423
-8% -$171K 0.01% 894
2016
Q2 		$1.99M Sell
18,788
-761
-4% -$84.9K 0.01% 869
2016
Q1 		$2.18M Buy
19,549
+4,073
+26% +$515K 0.01% 850
2015
Q4 		$2.42M Buy
15,476
+229
+2% +$33.3K 0.01% 749
2015
Q3 		$2M Sell
15,247
-3,665
-19% -$588K 0.01% 769
2015
Q2 		$3.29M Buy
18,912
+2,196
+13% +$395K 0.02% 633
2015
Q1 		$2.88M Buy
16,716
+1,469
+10% +$224K 0.01% 662
2014
Q4 		$1.97M Sell
15,247
-8,904
-37% -$1.15M 0.01% 755
2014
Q3 		$3.11M Hold
24,151
– – 0.02% 620
2014
Q2 		$2.14M Sell
24,151
-7,580
-24% -$729K 0.01% 789
2014
Q1 		$2.98M Sell
31,731
-8,508
-21% -$870K 0.01% 721
2013
Q4 		$4.55M Buy
40,239
+7,921
+25% +$714K 0.02% 564
2013
Q3 		$2.55M Buy
32,318
+9,212
+40% +$673K 0.01% 726
2013
Q2 		$1.52M Buy
+23,106
New +$1.49M 0.01% 890

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Panagora Asset Management's UTHR Position: Q2 2026 in Review

Panagora Asset Management reduced its United Therapeutics (UTHR) stake by 92% in Q2 2026, selling an estimated $18.1M and leaving 2,880 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Panagora Asset Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.7M in Q4 2020. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Panagora Asset Management held 2,880 shares of United Therapeutics worth $1.56M as of Q2 2026.
  • Panagora Asset Management sold 32,073 United Therapeutics shares in Q2 2026, an estimated $18.1M.
  • United Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #674 holding.
  • Panagora Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Panagora Asset Management's United Therapeutics position peaked at $30.7M in Q4 2020.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.